Zubieta Jon-Kar, Ketter Terence A, Bueller Joshua A, Xu Yanjun, Kilbourn Michael R, Young Elizabeth A, Koeppe Robert A
Department of Psychiatry and Mental Health Research Institute, University of Michigan, 205 Zina Pitcher Place, Ann Arbor, MI 48109-0720, USA.
Arch Gen Psychiatry. 2003 Nov;60(11):1145-53. doi: 10.1001/archpsyc.60.11.1145.
Human affective responses appear to be regulated by limbic and paralimbic circuits. However, much less is known about the neurochemical systems engaged in this regulation. The mu-opioid neurotransmitter system is distributed in, and thought to regulate the function of, brain regions centrally implicated in affective processing.
To examine the involvement of mu-opioid neurotransmission in the regulation of affective states in healthy human volunteers.
Measures of mu-opioid receptor availability in vivo were obtained with positron emission tomography and the mu-opioid receptor selective radiotracer [11C]carfentanil during a neutral state and during a sustained sadness state. Subtraction analyses of the binding potential maps were then performed within subjects, between conditions, on a voxel-by-voxel basis.
Imaging center at a university medical center.
Fourteen healthy female volunteers. Intervention Sustained neutral and sadness states, randomized and counterbalanced in order, elicited by the cued recall of an autobiographical event associated with that emotion.
Changes in mu-opioid receptor availability and negative and positive affect ratings between conditions. Increases or reductions in the in vivo receptor measure reflect deactivation or activation of neurotransmitter release, respectively.
The sustained sadness condition was associated with a statistically significant deactivation in mu-opioid neurotransmission in the rostral anterior cingulate, ventral pallidum, amygdala, and inferior temporal cortex. This deactivation was reflected by increases in mu-opioid receptor availability in vivo. The deactivation of mu-opioid neurotransmission in the rostral anterior cingulate, ventral pallidum, and amygdala was correlated with the increases in negative affect ratings and the reductions in positive affect ratings during the sustained sadness state.
These data demonstrate dynamic changes in mu-opioid neurotransmission in response to an experimentally induced negative affective state. The direction and localization of these responses confirms the role of the mu-opioid receptor system in the physiological regulation of affective experiences in humans.
人类的情感反应似乎受边缘系统和边缘旁系统回路调节。然而,对于参与这种调节的神经化学系统,我们了解得要少得多。μ-阿片类神经递质系统分布于对情感加工至关重要的脑区,并被认为可调节这些脑区的功能。
研究μ-阿片类神经传递在健康人类志愿者情感状态调节中的作用。
在中性状态和持续悲伤状态下,采用正电子发射断层扫描及μ-阿片受体选择性放射性示踪剂[11C]卡芬太尼,获取体内μ-阿片受体可用性的测量值。然后在受试者内部,逐体素地对不同状态间的结合潜能图进行减法分析。
大学医学中心的影像中心。
14名健康女性志愿者。干预通过对与某种情绪相关的自传体事件进行线索回忆,按随机和平衡顺序引发持续的中性和悲伤状态。
不同状态间μ-阿片受体可用性的变化以及消极和积极情感评分。体内受体测量值的增加或减少分别反映神经递质释放的失活或激活。
持续悲伤状态与喙前扣带回、腹侧苍白球、杏仁核及颞下回皮质中μ-阿片类神经传递的显著失活相关。这种失活表现为体内μ-阿片受体可用性增加。喙前扣带回、腹侧苍白球和杏仁核中μ-阿片类神经传递的失活与持续悲伤状态下消极情感评分增加及积极情感评分降低相关。
这些数据表明,μ-阿片类神经传递会因实验诱导的消极情感状态而发生动态变化。这些反应的方向和定位证实了μ-阿片受体系统在人类情感体验生理调节中的作用。